Weekly News – November 17

Meet our 2023 Sponsors

2024 Sponsorships Now Available

Please Consider Sponsoring CRC’s Content
Click Here

CRC Allocators Conference:

Andrew Herenstein of Monarch on Opportunity Set

Click on the screenshot to play the video

Name that tune!

Celsius getting out of dodge!

Make-wholes faring well

Our take:
The latest abusive trend or creative financing?
Tell us what you think here

Puerto Rico still a dogfight

Exclusive Content

Find it on Reorg here

Tehum gets new mediator

Inflation coming down

Exclusive Content

Find it on CreditSights here

but higher rates pressuring credit

Exclusive Content

Find it here on S&P Global (one-time free registration required)

What we’re reading

Thank you for Inviting the CRC to the Beard Investing Conference

Thank you for making the
CRC Allocators Conference
a Success

Learn More!

CRC weighs in on Serta

The Academics Speak Up
Purdue Pharma

Purdue Pharma is the gift that keeps on giving. This is our third installment on the twists and turns this case has taken through the Courts. You can read our first installment here, and our second here.

All bets came off the table when the Supreme Court decided to reshuffle the deck by taking on the appeal of the 2nd Circuitâ€™s decision. Not only did SCOTUS take the unusual step of taking on this big ticket issue in BK cases but it also stopped the lower courtâ€™s decision in its tracks putting the breaks on the entire enchilada. We decided to consult with our expert Academic Contributors for our inaugural feature the Academics Speak Up to get their takes on the latest developments.

We are excited to bring you the varying perspectives of Prof. Tony Casey, Prof. Samir Parikh and Prof. Ralph Brubaker.

Read on here, you wonâ€™t be disappointed.

Read more on Purdue Pharma